Back to search

Article

Aldehyde breath test as a disease marker in patients with esophageal and hypopharyngeal squamous cell carcinoma

2020-06-10

Abstract excerpt

<title>Abstract</title> <p>Background Patients with inactive aldehyde dehydrogenase 2 (ALDH2) are at high risk for esophageal squamous cell carcinoma (ESCC) and hypopharyngeal squamous cell carcinoma (HPSCC). The aldehyde breath test (ABT) may demonstrate ALDH2 gene polymorphisms. We evaluated the usefulness of the ABT in patients with ESCC and HPSCC. Methods The SCC group consisted of 100 patients who were tre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
38789772-4534-5f81-a7b8-c61ffe9ef5de
DOI
10.21203/rs.3.rs-30598/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aldehyde breath test as a disease marker in patients with esophageal and hypopharyngeal squamous cell carcinomaDOI 10.21203/rs.3.rs-30598/v1
Select a neighboring publication to make it the new centre.